About
Technology
Issues
FAQ
Links
Official Page
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.